Developed Markets Segment — Net Sales
Viatris Developed Markets Segment — Net Sales decreased by 10.3% to $2.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.7%, from $1.90B to $2.03B. Over 4 years (FY 2021 to FY 2025), Developed Markets Segment — Net Sales shows a downward trend with a -4.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful product penetration or pricing strength in mature markets, while a decrease may indicate competitive pressure or patent expirations.
Detailed definition
Represents the total revenue generated from the sale of pharmaceutical products within established, high-income geograph...
Peer comparison
Commonly reported by global pharmaceutical companies as 'Revenue by Geography' or 'Regional Segment Sales'.
vtrs_segment_developed_markets_segment_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.64B | $2.66B | $2.56B | $2.48B | $2.48B | $2.43B | $2.40B | $2.17B | $2.35B | $2.41B | $2.35B | $2.17B | $2.33B | $2.31B | $2.16B | $1.90B | $2.13B | $2.27B | $2.26B | $2.03B |
| QoQ Change | — | +0.6% | -3.6% | -3.3% | +0.1% | -1.9% | -1.1% | -9.7% | +8.5% | +2.3% | -2.6% | -7.4% | +7.0% | -0.7% | -6.6% | -11.9% | +12.2% | +6.4% | -0.3% | -10.3% |
| YoY Change | — | — | — | — | -6.1% | -8.4% | -6.1% | -12.3% | -5.1% | -0.9% | -2.4% | +0.1% | -1.2% | -4.2% | -8.1% | -12.6% | -8.4% | -1.8% | +4.8% | +6.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's developed markets segment — net sales?
- Viatris (VTRS) reported developed markets segment — net sales of $2.03B in Q1 2026.
- How has Viatris's developed markets segment — net sales changed year-over-year?
- Viatris's developed markets segment — net sales increased by 6.7% year-over-year, from $1.90B to $2.03B.
- What is the long-term trend for Viatris's developed markets segment — net sales?
- Over 4 years (2021 to 2025), Viatris's developed markets segment — net sales has grown at a -4.8% compound annual growth rate (CAGR), from $10.43B to $8.55B.
- What does developed markets segment — net sales mean?
- Total revenue earned from sales in developed geographic markets.